{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T07:25:12Z","timestamp":1786951512776,"version":"build-2736575974"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T00:00:00Z","timestamp":1782691200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T00:00:00Z","timestamp":1782691200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Mol Histol"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1007\/s10735-026-10868-2","type":"journal-article","created":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T03:28:12Z","timestamp":1781839692000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Astragaloside II suppresses colorectal cancer progression by upregulating LGALS4 expression"],"prefix":"10.1007","volume":"57","author":[{"given":"Yingying","family":"Su","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rongqiang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiyong","family":"Shao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,29]]},"reference":[{"issue":"2","key":"10868_CR1","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1007\/s10555-023-10158-3","volume":"43","author":"R Abedizadeh","year":"2024","unstructured":"Abedizadeh R, Majidi F, Khorasani HR, Abedi H, Sabour D (2024) Colorectal cancer: a comprehensive review of carcinogenesis, diagnosis, and novel strategies for classified treatments. Cancer Metastasis Rev 43(2):729\u2013753. https:\/\/doi.org\/10.1007\/s10555-023-10158-3","journal-title":"Cancer Metastasis Rev"},{"issue":"10","key":"10868_CR2","first-page":"11353","volume":"13","author":"A Acharjee","year":"2021","unstructured":"Acharjee A, Agarwal P, Nash K, Bano S, Rahman T, Gkoutos GV (2021) Immune infiltration and prognostic and diagnostic use of LGALS4 in colon adenocarcinoma and bladder urothelial carcinoma. Am J Transl Res 13(10):11353\u201311363","journal-title":"Am J Transl Res"},{"issue":"5","key":"10868_CR3","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1007\/s13238-016-0262-9","volume":"7","author":"ZQ Cao","year":"2016","unstructured":"Cao ZQ, Guo XL (2016) The role of galectin-4 in physiology and diseases. Protein Cell 7(5):314\u2013324. https:\/\/doi.org\/10.1007\/s13238-016-0262-9","journal-title":"Protein Cell"},{"issue":"8","key":"10868_CR4","doi-asserted-by":"publisher","first-page":"e0289535","DOI":"10.1371\/journal.pone.0289535","volume":"18","author":"T Cheraghi-Shavi","year":"2023","unstructured":"Cheraghi-Shavi T, Jalal R, Minuchehr Z (2023) TGM2, HMGA2, FXYD3, and LGALS4 genes as biomarkers in acquired oxaliplatin resistance of human colorectal cancer: a systems biology approach. PLoS ONE 18(8):e0289535. https:\/\/doi.org\/10.1371\/journal.pone.0289535","journal-title":"PLoS ONE"},{"issue":"4","key":"10868_CR5","doi-asserted-by":"publisher","first-page":"e0322319","DOI":"10.1371\/journal.pone.0322319","volume":"20","author":"T Cheraghi-Shavi","year":"2025","unstructured":"Cheraghi-Shavi T, Jalal R, Minuchehr Z, Mahjoubi F (2025) Correction: TGM2, HMGA2, FXYD3, and LGALS4 genes as biomarkers in acquired oxaliplatin resistance of human colorectal cancer: a systems biology approach. PLoS ONE 20(4):e0322319. https:\/\/doi.org\/10.1371\/journal.pone.0322319","journal-title":"PLoS ONE"},{"issue":"12\u201313","key":"10868_CR6","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1055\/s-0035-1546117","volume":"81","author":"L Di Cesare Mannelli","year":"2015","unstructured":"Di Cesare Mannelli L, Zanardelli M, Bartolucci G, Karioti A, Bilia AR, Vannacci A, Mugelli A, Ghelardini C (2015) In vitro evidence for the use of astragali radix extracts as adjuvant against oxaliplatin-induced neurotoxicity. Planta Med 81(12\u201313):1045\u20131055. https:\/\/doi.org\/10.1055\/s-0035-1546117","journal-title":"Planta Med"},{"issue":"1","key":"10868_CR7","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1007\/s11684-020-0783-8","volume":"15","author":"B Dou","year":"2021","unstructured":"Dou B, Li S, Wei L, Wang L, Zhu S, Wang Z, Ke Z, Chen K, Wang Z (2021) Astragaloside IV suppresses post-ischemic natural killer cell infiltration and activation in the brain: involvement of histone deacetylase inhibition. Front Med 15(1):79\u201390. https:\/\/doi.org\/10.1007\/s11684-020-0783-8","journal-title":"Front Med"},{"key":"10868_CR8","doi-asserted-by":"publisher","unstructured":"Gao G, Jiang X, Ma J, Wang Z (2025) Astragaloside II-loaded neutrophil nanocarrier drug delivery system for liver cancer treatment. J Biomater Appl . https:\/\/doi.org\/10.1177\/08853282251381435","DOI":"10.1177\/08853282251381435"},{"issue":"6","key":"10868_CR9","first-page":"509","volume":"39","author":"X He","year":"2023","unstructured":"He X, Wan S, He Q, Hou J (2023) [Identification of immune-related prognostic signature for colon adenocarcinoma based on weighted gene co-expression network analysis]. Xi bao yu fen zi Mian yi xue za zhi= Chin J Cell Mol Immunol 39(6):509\u2013515","journal-title":"Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi"},{"key":"10868_CR10","doi-asserted-by":"publisher","unstructured":"Jin Y, Deng J, Luo B, Zhong Y, Yu S (2022) Construction and validation of an immune-related genes prognostic index (IRGPI) model in colon cancer. Front Endocrinol (Lausanne). https:\/\/doi.org\/10.3389\/fendo.2022.963382","DOI":"10.3389\/fendo.2022.963382"},{"key":"10868_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1139\/bcb-2024-0218","volume":"103","author":"A Kamarudin","year":"2025","unstructured":"Kamarudin A, Abu N (2025) Revisiting galectin-1, -3, -4, and \u2013\u20099 as biotargets for colorectal cancer. Biochem Cell Biol 103:1\u201310. https:\/\/doi.org\/10.1139\/bcb-2024-0218","journal-title":"Biochem Cell Biol"},{"issue":"7","key":"10868_CR12","doi-asserted-by":"publisher","first-page":"e13987","DOI":"10.1111\/eci.13987","volume":"53","author":"S Kaur","year":"2023","unstructured":"Kaur S, Singh J, Kaur M (2023) Multifaceted role of galectin-4 in cancer: a systematic review. Eur J Clin Invest 53(7):e13987. https:\/\/doi.org\/10.1111\/eci.13987","journal-title":"Eur J Clin Invest"},{"issue":"1","key":"10868_CR13","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.bbrc.2017.07.052","volume":"491","author":"B Li","year":"2017","unstructured":"Li B, Wang F, Liu N, Shen W, Huang T (2017a) Astragaloside IV inhibits progression of glioma via blocking MAPK\/ERK signaling pathway. Biochem Biophys Res Commun 491(1):98\u2013103. https:\/\/doi.org\/10.1016\/j.bbrc.2017.07.052","journal-title":"Biochem Biophys Res Commun"},{"key":"10868_CR16","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.jchromb.2017.08.012","volume":"1063","author":"X Li","year":"2017","unstructured":"Li X, Pi Z, Liu S, Wang W, Liu Z, Song F (2017b) Online monitoring of astragaloside II metabolism using a homemade cultural device coupled with microdialysis and ultra-performance liquid chromatography-mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci 1063:141\u2013148. https:\/\/doi.org\/10.1016\/j.jchromb.2017.08.012","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"issue":"12","key":"10868_CR14","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1089\/jmf.2024.k.0057","volume":"27","author":"J Li","year":"2024","unstructured":"Li J, Niu Y, Yuan L, Jiang W, Jiao T, Dou H, Nan Y (2024) Research progress in the medicine-food dual use of astragalus for gastrointestinal tumors. J Med Food 27(12):1145\u20131157. https:\/\/doi.org\/10.1089\/jmf.2024.k.0057","journal-title":"J Med Food"},{"issue":"3","key":"10868_CR15","doi-asserted-by":"publisher","first-page":"126","DOI":"10.3892\/ol.2025.14873","volume":"29","author":"S Li","year":"2025","unstructured":"Li S, Yang K, Ye J, Xu C, Qin Z, Chen Y, Yu L, Zhou T, Sun B, Xu J (2025) LGALS4 inhibits glycolysis and promotes apoptosis of colorectal cancer cells via beta\u2013catenin signaling. Oncol Lett 29(3):126. https:\/\/doi.org\/10.3892\/ol.2025.14873","journal-title":"Oncol Lett"},{"key":"10868_CR17","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.jchromb.2015.07.059","volume":"1026","author":"R Liu","year":"2016","unstructured":"Liu R, Ma R, Yu C, Bi CW, Yin Y, Xu H, Shang H, Bi K, Li Q (2016) Quantitation of eleven active compounds of Aidi injection in rat plasma and its application to comparative pharmacokinetic study. J Chromatogr B Analyt Technol Biomed Life Sci 1026:105\u2013113. https:\/\/doi.org\/10.1016\/j.jchromb.2015.07.059","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"issue":"4","key":"10868_CR18","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1080\/08923973.2021.1936013","volume":"43","author":"W Liu","year":"2021","unstructured":"Liu W, Chen H, Wang D (2021) Protective role of astragaloside IV in gastric cancer through regulation of microRNA-195-5p-mediated PD-L1. Immunopharmacol Immunotoxicol 43(4):443\u2013451. https:\/\/doi.org\/10.1080\/08923973.2021.1936013","journal-title":"Immunopharmacol Immunotoxicol"},{"issue":"3","key":"10868_CR19","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1007\/s12272-024-01489-y","volume":"47","author":"YX Liu","year":"2024","unstructured":"Liu YX, Song XM, Dan LW, Tang JM, Jiang Y, Deng C, Zhang DD, Li YZ, Wang W (2024) Astragali radix: comprehensive review of its botany, phytochemistry, pharmacology and clinical application. Arch Pharm Res 47(3):165\u2013218. https:\/\/doi.org\/10.1007\/s12272-024-01489-y","journal-title":"Arch Pharm Res"},{"issue":"1","key":"10868_CR20","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1142\/S0192415X25500065","volume":"53","author":"Q Lu","year":"2025","unstructured":"Lu Q, Jiang J, Wang X, Wang R, Han X (2025) Advancements in the research of astragalus membranaceus for the treatment of colorectal cancer. Am J Chin Med 53(1):119\u2013146. https:\/\/doi.org\/10.1142\/S0192415X25500065","journal-title":"Am J Chin Med"},{"key":"10868_CR21","doi-asserted-by":"publisher","unstructured":"Michalak M, Golde V, Helm D, Kaltner H, Gebert J, Kopitz J (2022) Combining recombinase-mediated cassette exchange strategy with quantitative proteomic and phosphoproteomic analyses to inspect intracellular functions of the tumor suppressor galectin-4 in colorectal cancer cells. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms23126414","DOI":"10.3390\/ijms23126414"},{"issue":"2","key":"10868_CR22","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1136\/gutjnl-2022-327736","volume":"72","author":"E Morgan","year":"2023","unstructured":"Morgan E, Arnold M, Gini A, Lorenzoni V, Cabasag CJ, Laversanne M, Vignat J, Ferlay J, Murphy N, Bray F (2023) Global burden of colorectal cancer in 2020 and 2040: incidence and mortality estimates from GLOBOCAN. Gut 72(2):338\u2013344. https:\/\/doi.org\/10.1136\/gutjnl-2022-327736","journal-title":"Gut"},{"issue":"11","key":"10868_CR23","doi-asserted-by":"publisher","first-page":"932","DOI":"10.2174\/1568009621666211103113339","volume":"21","author":"M Pashirzad","year":"2021","unstructured":"Pashirzad M, Khorasanian R, Fard MM, Arjmand MH, Langari H, Khazaei M, Soleimanpour S, Rezayi M, Ferns GA, Hassanian SM, Avan A (2021) The therapeutic potential of MAPK\/ERK inhibitors in the treatment of colorectal cancer. Curr Cancer Drug Targets 21(11):932\u2013943. https:\/\/doi.org\/10.2174\/1568009621666211103113339","journal-title":"Curr Cancer Drug Targets"},{"issue":"1","key":"10868_CR24","doi-asserted-by":"publisher","first-page":"8238","DOI":"10.1038\/s41598-025-89018-9","volume":"15","author":"S Qiao","year":"2025","unstructured":"Qiao S, Li X, Yang S, Hua H, Mao C, Lu W (2025) Investigating the PI3K\/AKT\/mTOR axis in Buzhong Yiqi Decoction\u2019s anti-colorectal cancer activity. Sci Rep 15(1):8238. https:\/\/doi.org\/10.1038\/s41598-025-89018-9","journal-title":"Sci Rep"},{"key":"10868_CR25","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.pep.2015.09.026","volume":"118","author":"JK Rustiguel","year":"2016","unstructured":"Rustiguel JK, Kumagai PS, Dias-Baruffi M, Costa-Filho AJ, Nonato MC (2016) Recombinant expression, purification and preliminary biophysical and structural studies of C-terminal carbohydrate recognition domain from human galectin-4. Protein Expr Purif 118:39\u201348. https:\/\/doi.org\/10.1016\/j.pep.2015.09.026","journal-title":"Protein Expr Purif"},{"key":"10868_CR26","doi-asserted-by":"publisher","unstructured":"Slamova K, Cerveny J, Meszaros Z, Friede T, Vrbata D, Kren V, Bojarova P (2023) Oligosaccharide ligands of galectin-4 and its subunits: multivalency scores highly. Molecules. https:\/\/doi.org\/10.3390\/molecules28104039","DOI":"10.3390\/molecules28104039"},{"key":"10868_CR27","doi-asserted-by":"publisher","unstructured":"Smith HG, Nilsson PJ, Shogan BD, Harji D, Gambacorta MA, Romano A, Brandl A, Qvortrup C (2024) Neoadjuvant treatment of colorectal cancer: comprehensive review. BJS Open. https:\/\/doi.org\/10.1093\/bjsopen\/zrae038","DOI":"10.1093\/bjsopen\/zrae038"},{"issue":"46","key":"10868_CR28","doi-asserted-by":"publisher","first-page":"17924","DOI":"10.1021\/acs.jafc.3c05405","volume":"71","author":"S Song","year":"2023","unstructured":"Song S, Li Y, Liu X, Yu J, Li Z, Liang K, Wang S, Zhang J (2023) Study on the biotransformation and activities of astragalosides from astragali radix in vitro and in vivo. J Agric Food Chem 71(46):17924\u201317946. https:\/\/doi.org\/10.1021\/acs.jafc.3c05405","journal-title":"J Agric Food Chem"},{"key":"10868_CR29","doi-asserted-by":"publisher","unstructured":"Underwood PW, Ruff SM, Pawlik TM (2024) Update on targeted therapy and immunotherapy for metastatic colorectal cancer. Cells. https:\/\/doi.org\/10.3390\/cells13030245","DOI":"10.3390\/cells13030245"},{"key":"10868_CR30","doi-asserted-by":"publisher","first-page":"2431","DOI":"10.2147\/DDDT.S170840","volume":"12","author":"X Wang","year":"2018","unstructured":"Wang X, Gao Y, Tian N, Zou D, Shi Y, Zhang N (2018) Astragaloside IV improves renal function and fibrosis via inhibition of miR-21-induced podocyte dedifferentiation and mesangial cell activation in diabetic mice. Drug Des Devel Ther 12:2431\u20132442. https:\/\/doi.org\/10.2147\/DDDT.S170840","journal-title":"Drug Des Devel Ther"},{"issue":"10","key":"10868_CR31","doi-asserted-by":"publisher","first-page":"1144","DOI":"10.1097\/CM9.0000000000002661","volume":"136","author":"Y Wang","year":"2023","unstructured":"Wang Y, Zhang Z, Cheng Z, Xie W, Qin H, Sheng J (2023) Astragaloside in cancer chemoprevention and therapy. Chin Med J (Engl) 136(10):1144\u20131154. https:\/\/doi.org\/10.1097\/CM9.0000000000002661","journal-title":"Chin Med J (Engl)"},{"issue":"14","key":"10868_CR32","doi-asserted-by":"publisher","first-page":"23787","DOI":"10.18632\/oncotarget.15865","volume":"8","author":"MM Wu","year":"2017","unstructured":"Wu MM, Li CF, Lin LF, Wang AS, Pu YS, Wang HH, Mar AC, Chen CJ, Lee TC (2017) Promoter hypermethylation of LGALS4 correlates with poor prognosis in patients with urothelial carcinoma. Oncotarget 8(14):23787\u201323802. https:\/\/doi.org\/10.18632\/oncotarget.15865","journal-title":"Oncotarget"},{"issue":"1","key":"10868_CR33","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.bbrc.2019.06.003","volume":"516","author":"T Yamashita","year":"2019","unstructured":"Yamashita T, Mori Y, Alzaaqi SM, Yashiro M, Sawada T, Hirakawa K, Nakada H (2019) Induction of Trop-2 expression through the binding of galectin-3 to MUC1. Biochem Biophys Res Commun 516(1):44\u201349. https:\/\/doi.org\/10.1016\/j.bbrc.2019.06.003","journal-title":"Biochem Biophys Res Commun"},{"key":"10868_CR34","doi-asserted-by":"publisher","first-page":"114656","DOI":"10.1016\/j.jep.2021.114656","volume":"282","author":"M Yang","year":"2022","unstructured":"Yang M, Shen C, Zhu SJ, Zhang Y, Jiang HL, Bao YD, Yang GY, Liu JP (2022) Chinese patent medicine Aidi injection for cancer care: an overview of systematic reviews and meta-analyses. J Ethnopharmacol 282:114656. https:\/\/doi.org\/10.1016\/j.jep.2021.114656","journal-title":"J Ethnopharmacol"},{"issue":"6","key":"10868_CR35","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.1016\/j.bbadis.2017.03.006","volume":"1863","author":"C Yu","year":"2017","unstructured":"Yu C, Pan S, Dong M, Niu Y (2017) Astragaloside IV attenuates lead acetate-induced inhibition of neurite outgrowth through activation of Akt-dependent Nrf2 pathway in vitro. Biochim Biophys Acta Mol Basis Dis 1863(6):1195\u20131203. https:\/\/doi.org\/10.1016\/j.bbadis.2017.03.006","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"10868_CR36","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1016\/j.jare.2025.04.028","volume":"80","author":"J Yuan","year":"2026","unstructured":"Yuan J, Tao Y, Wang M, Chen Y, Han X, Wu H, Shi H, Huang F, Wu X (2026) Astragaloside II, a natural saponin, facilitates remyelination in demyelination neurological diseases via p75NTR receptor mediated beta-catenin\/Id2\/MBP signaling axis in oligodendrocyte precursor cells. J Adv Res 80:577\u2013591. https:\/\/doi.org\/10.1016\/j.jare.2025.04.028","journal-title":"J Adv Res"},{"issue":"12","key":"10868_CR37","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1007\/s12032-023-02221-4","volume":"40","author":"F Yulak","year":"2023","unstructured":"Yulak F, Filiz AK, Joha Z, Ergul M (2023) Mechanism of anticancer effect of ETP-45658, a PI3K\/AKT\/mTOR pathway inhibitor on HT-29 Cells. Med Oncol 40(12):341. https:\/\/doi.org\/10.1007\/s12032-023-02221-4","journal-title":"Med Oncol"},{"issue":"23","key":"10868_CR38","doi-asserted-by":"publisher","first-page":"5883","DOI":"10.7150\/jca.32267","volume":"10","author":"GL Zhang","year":"2019","unstructured":"Zhang GL, Pan LL, Huang T, Wang JH (2019) The transcriptome difference between colorectal tumor and normal tissues revealed by single-cell sequencing. J Cancer 10(23):5883\u20135890. https:\/\/doi.org\/10.7150\/jca.32267","journal-title":"J Cancer"},{"key":"10868_CR39","doi-asserted-by":"publisher","first-page":"115625","DOI":"10.1016\/j.biopha.2023.115625","volume":"167","author":"T Ziyang","year":"2023","unstructured":"Ziyang T, Xirong H, Chongming A, Tingxin L (2023) The potential molecular pathways of astragaloside-IV in colorectal cancer: a systematic review. Biomed Pharmacother 167:115625. https:\/\/doi.org\/10.1016\/j.biopha.2023.115625","journal-title":"Biomed Pharmacother"}],"container-title":["Journal of Molecular Histology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10735-026-10868-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10735-026-10868-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10735-026-10868-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T06:49:08Z","timestamp":1786949348000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10735-026-10868-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,29]]},"references-count":39,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["10868"],"URL":"https:\/\/doi.org\/10.1007\/s10735-026-10868-2","relation":{},"ISSN":["1567-2379","1567-2387"],"issn-type":[{"value":"1567-2379","type":"print"},{"value":"1567-2387","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,29]]},"assertion":[{"value":"10 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All procedures were conducted in accordance with the principle of Replacement, Reduction, and Refinement (3Rs) and all animal procedures were approved by the Animal Ethics Committee of Shaanxi University of Chinese Medicine (Ethics Number: SUCMDL202609013).","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"199"}}